A computational study conducted on genetic data from 5.62 million ethnically diverse individuals over 60 years of age, found moderate or high use of temisartan, a drug currently prescribed for people with high blood pressure, is associated with lower risk of Alzheimer’s disease (AD) and dementia in African Americans but not European Americans.
Senior author of the paper, Feixiong Cheng, PhD, scientist at Cleveland Clinic’s Lerner Research Institute said, “The findings suggest that future clinical trials should prioritize including patients from minority populations to find or reinforce these associations.”
